Standard
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment. / Hallager, Sofie; Ladelund, Steen; Weis, Nina.
I:
Journal of Hepatology, Bind 67, Nr. 2, 08.2017, s. 427-428.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
Harvard
Hallager, S, Ladelund, S
& Weis, N 2017, '
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment',
Journal of Hepatology, bind 67, nr. 2, s. 427-428.
https://doi.org/10.1016/j.jhep.2017.02.035APA
Hallager, S., Ladelund, S.
, & Weis, N. (2017).
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment.
Journal of Hepatology,
67(2), 427-428.
https://doi.org/10.1016/j.jhep.2017.02.035Vancouver
Hallager S, Ladelund S
, Weis N.
Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment.
Journal of Hepatology. 2017 aug.;67(2):427-428.
https://doi.org/10.1016/j.jhep.2017.02.035Author
Hallager, Sofie ; Ladelund, Steen ; Weis, Nina. / Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment. I: Journal of Hepatology. 2017 ; Bind 67, Nr. 2. s. 427-428.
Bibtex
@article{260d98b806de48a2ad14c3c7e94175e6,
title = "Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment",
author = "Sofie Hallager and Steen Ladelund and Nina Weis",
year = "2017",
month = aug,
doi = "10.1016/j.jhep.2017.02.035",
language = "English",
volume = "67",
pages = "427--428",
journal = "Journal of Hepatology, Supplement",
issn = "0169-5185",
publisher = "Elsevier",
number = "2",
}
RIS
TY - JOUR
T1 - Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment
AU - Hallager, Sofie
AU - Ladelund, Steen
AU - Weis, Nina
PY - 2017/8
Y1 - 2017/8
U2 - 10.1016/j.jhep.2017.02.035
DO - 10.1016/j.jhep.2017.02.035
M3 - Comment/debate
C2 - 28435039
AN - SCOPUS:85019074905
VL - 67
SP - 427
EP - 428
JO - Journal of Hepatology, Supplement
JF - Journal of Hepatology, Supplement
SN - 0169-5185
IS - 2
ER -
